First Africa-based clinical trial for novel type 2 oral poliovirus vaccine. Cooper LV, Blake IM. Lancet 2024 Feb 22:S0140-6736(24)00053-9. doi: 10.1016/S0140-6736(24)00053.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cooper LV, Blake IM. First Africa-based clinical trial for novel type 2 oral poliovirus vaccine. Lancet 2024 Feb 22:S0140-6736(24)00053-9. doi: 10.1016/S0140-6736(24)00053.
PMID: 38402883